STAGE IIB PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IIB PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat pancreatic cancer
Disease control OngoingThis study tests whether a combination of two drugs, lenvatinib and pembrolizumab, can help control advanced pancreatic cancer that cannot be removed by surgery. The drugs work by blocking cancer growth signals and boosting the immune system to attack cancer cells. The trial invo…
Matched conditions: STAGE IIB PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
New drug cocktail aims to starve pancreatic tumors
Disease control OngoingThis early-stage trial tests a combination of two drugs—calaspargase and cobimetinib—in about 15 people with advanced pancreatic cancer that has spread. Calaspargase works by cutting off a key nutrient that cancer cells need to grow, while cobimetinib blocks a protein that helps …
Matched conditions: STAGE IIB PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC